In today's diverse healthcare world, meeting the specific needs of Muslim patients is more important than ever. However, without clear guidelines, healthcare professionals often face difficulties in providing care that aligns with Islamic values. To solve this, experts in Malaysia are developing a n
Dearborn, Michigan, is gearing up to pay tribute to a man who devoted his life to public service. John "Jack" O'Reilly Jr. , who served as Dearborn's Mayor for 15 years and City Council President for 17, passed away on New Year's Day at the age of 76. His family was by his side. The memorial service
YNW Melly, a Florida rapper, recently appeared in court with a different hairdo after spending over 2, 159 days behind bars. His new style features a shorter, messy afro instead of his usual dreadlocks, and he seems to have had a lineup as well. This change in appearance comes at a pivotal moment fo
Ever wondered how to make your work tools smarter? Well, integrating AI into your favorite Microsoft Office alternative is easier than you think! ZDNET's recommendations are the result of hours of testing and research. They gather data from various sources, including vendor listings, reviews from cu
Scientists recently explored a clever way to remove nickel ions from wastewater using powdered clam shells. They filled a glass column with the shells and tested how well the setup worked by changing the flow rate. The best results showed that 87. 68% of nickel ions were removed when the flow rate w
Immune treatments, or immune checkpoint inhibitors (ICIs), are game-changers for some people with far-advanced solid tumors. But when it comes to biliary tract cancer (BTC), doctors are still figuring out who gets the most benefit from these treatments. A recent trial focused on pembrolizumab, an IC
When people get a stem cell transplant from someone else (called allogeneic transplant), their immune system takes a big hit. This makes them super vulnerable to infections from bacteria, viruses, and fungi. Even with better protection strategies, bacterial infections in the bloodstream (called BSIs
Meet rimegepant, a new drug that blocks certain signals in your brain to stop migraines. It's been tested in labs and found to work, but what about in the real world? That's what the GAINER study set out to find. This study, happening in multiple places, looked at how well rimegepant works and how t
Immune-checkpoint inhibitors (ICIs) have emerged as a powerful tool in the fight against advanced squamous cell lung cancer (LUSC). These drugs offer a glimmer of hope for patients who haven't found success with other treatments. But it's not a one-size-fits-all solution—some patients don't respond
The Y chromosome, which doesn't recombine, holds vital clues about paternal human history. Scientists have noticed something puzzling: some Y chromosome branches are much longer than others, especially those that are very different from the standard human Y chromosome. This length variation isn't ex
